BiotechTube

Drotrecogin Alfa (Activated) + Unfractionated heparin + Low molecular weight heparin

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Sepsis

Conditions

Sepsis

Trial Timeline

Dec 1, 2002 → Aug 1, 2005

NCT ID
NCT00049777

About Drotrecogin Alfa (Activated) + Unfractionated heparin + Low molecular weight heparin

Drotrecogin Alfa (Activated) + Unfractionated heparin + Low molecular weight heparin is a approved stage product being developed by Eli Lilly for Sepsis. The current trial status is completed. This product is registered under clinical trial identifier NCT00049777. Target conditions include Sepsis.

What happened to similar drugs?

8 of 18 similar drugs in Sepsis were approved

Approved (8) Terminated (1) Active (9)
✅MeropenemPfizerApproved
✅ImipenemMerckApproved
✅Drotrecogin Alfa (activated)Eli LillyApproved
✅Drotrecogin alfa (activated)Eli LillyApproved
✅drotrecogin alfa (activated)Eli LillyApproved
✅drotrecogin alfa (activated)Eli LillyApproved
✅Azithromycin + Azithromycin and amoxicillin + PlaceboMerckApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00049777ApprovedCompleted

Competing Products

20 competing products in Sepsis

See all competitors
ProductCompanyStageHype Score
Alkaline Phosphatase + PlaceboAM-PharmaPhase 2
25
Drotrecogin alfa (activated)Eli LillyPhase 2
35
MeropenemPfizerApproved
43
ImipenemMerckApproved
39
CefiderocolShionogiPhase 1
29
eritoran tetrasodium + PlaceboEisaiPhase 3
40
E5564EisaiPhase 2
35
Drotrecogin Alfa (Activated) + placeboEli LillyPhase 3
40
Drotrecogin alfa (activated) + PlaceboEli LillyPhase 3
40
Drotrecogin Alfa (activated)Eli LillyApproved
43
Drotrecogin alfa (activated) + PlaceboEli LillyPhase 3
40
Drotrecogin alfa (activated) + PlaceboEli LillyPhase 3
40
sPLA2 InhibitorEli LillyPhase 1/2
32
Drotrecogin alfa (activated)Eli LillyApproved
43
drotrecogin alfa (activated)Eli LillyApproved
43
drotrecogin alfa (activated)Eli LillyApproved
43
AZD9773 (CytoFab)AstraZenecaPhase 2
35
AZD9773 + PlaceboAstraZenecaPhase 2
35
AZD9773 + PlaceboAstraZenecaPhase 2
35
AZD4144 + PlaceboAstraZenecaPhase 2
42